Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients-Reference-Cited by-同舟云学术

Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients

Published:2017-01-11 Issue:1 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Hill Penny¹,Cross Nicholas B¹,Barnett A Nicholas R²,Palmer Suetonia C³,Webster Angela C⁴⁵⁶

Affiliation:

1. Christchurch Public Hospital; Department of Nephrology; Christchurch New Zealand

2. Guy's and St Thomas' NHS Foundation Trust; Renal & Transplant Department; London UK

3. University of Otago Christchurch; Department of Medicine; 2 Riccarton Ave PO Box 4345 Christchurch New Zealand 8140

4. The University of Sydney; Sydney School of Public Health; Edward Ford Building A27 Sydney NSW Australia 2006

5. The University of Sydney at Westmead; Centre for Transplant and Renal Research, Westmead Millennium Institute; Westmead NSW Australia 2145

6. The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145

Publisher

Wiley

Subject

Pharmacology (medical)

Reference308 articles.

1. Induction immunosuppression with antithymocyte globulin in renal transplantation using a variable dose according to the absolute number of CD3+ T cells;Abouna;Transplantation Proceedings,1995

2. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring;Abouna;Transplantation,1995

3. The long-term effects of prophylactic OKT3 monoclonal antibody in cadaver kidney transplantation--a single-center, prospective, randomized study;Abramowicz;Transplantation,1992

4. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies;Abramowicz;Transplantation Proceedings,1995

5. OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival;Abramowicz;Kidney International,1996

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence;PLOS Pathogens;2024-08-22

2. Immunosuppressive drug combinations after kidney transplantation and post-transplant diabetes: A systematic review and meta-analysis;Transplantation Reviews;2024-07

3. Long‐term outcomes of two‐dose alemtuzumab induction in pediatric kidney transplantation;Pediatric Transplantation;2024-04-16

4. Antibody‐mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research Consortium;Pediatric Transplantation;2024-04-11

5. Transplant Candidates of 70+ Years Have Superior Survival If Receiving Pre-Emptively a Living Donor Kidney;Journal of Clinical Medicine;2024-03-23